This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User contributions
From Proteopedia
(Newest | Oldest) View (Newer 50) (Older 50) (20 | 50 | 100 | 250 | 500)
- 20:20, 30 April 2021 (hist) (diff) User:Alexandra Gredová (top)
- 20:19, 30 April 2021 (hist) (diff) Image:Fig 4 4 4.jpg (Fig. 4. Close-up to Arg158 residue interaction with Glu280 residue and Tyr268 residue. Hydrogen-bonds are shown here as red dashed lines (Erlandsen H, Stevens RC, 1999)) (top)
- 20:15, 30 April 2021 (hist) (diff) User:Alexandra Gredová
- 20:11, 30 April 2021 (hist) (diff) User:Alexandra Gredová
- 20:09, 30 April 2021 (hist) (diff) Image:Fig 5 5.png (Fig. 5. Close-up to Arg261 residue interaction with Gln304 residue and Thr238 residue. Hydrogen-bonds are shown here as red dashed lines (Erlandsen H, Stevens RC, 1999)) (top)
- 20:07, 30 April 2021 (hist) (diff) Image:Fig 4 4.jpg (Fig. 4. Close-up to Arg158 residue interaction with Glu280 residue and Tyr268 residue. Hydrogen-bonds are shown here as red dashed lines (Erlandsen H, Stevens RC, 1999)) (top)
- 20:04, 30 April 2021 (hist) (diff) Image:Fig 3 3.jpg (Fig. 3. Close-up to Arg408 residue interaction with Leu308 residue and Leu311 residue. Hydrogen-bonds are shown here as red dashed lines (Erlandsen H, Stevens RC, 1999)) (top)
- 19:58, 30 April 2021 (hist) (diff) User:Alexandra Gredová
- 19:57, 30 April 2021 (hist) (diff) User:Alexandra Gredová
- 19:52, 30 April 2021 (hist) (diff) User:Alexandra Gredová
- 19:50, 30 April 2021 (hist) (diff) Image:Obraz5.png (Fig. 5. Close-up to Arg261 residue interaction with Gln304 residue and Thr238 residue. Hydrogen-bonds are shown here as red dashed lines (Erlandsen H, Stevens RC, 1999)) (top)
- 19:49, 30 April 2021 (hist) (diff) Image:Obraz 5.png (Fig. 5. Close-up to Arg261 residue interaction with Gln304 residue and Thr238 residue. Hydrogen-bonds are shown here as red dashed lines (Erlandsen H, Stevens RC, 1999)) (top)
- 19:47, 30 April 2021 (hist) (diff) Image:Obraz 4.png (Fig. 4. Close-up to Arg158 residue interaction with Glu280 residue and Tyr268 residue. Hydrogen-bonds are shown here as red dashed lines (Erlandsen H, Stevens RC, 1999)) (top)
- 19:46, 30 April 2021 (hist) (diff) User:Alexandra Gredová
- 19:35, 30 April 2021 (hist) (diff) Image:Obraz 2.png (Fig. 2. Model of domain organization in one PAH monomer. Regulatory N-terminal domain is in blue, catalytic C-terminal domain is in yellow, tetramerization domain is in green, iron ion bound by the catalytic domain is in red (Erlandsen H, Stevens RC, 1999) (top)
- 19:32, 30 April 2021 (hist) (diff) Image:Obraz 1.jpg (Fig. 1. Crystal structure of human tetrameric PAH. Each monomere binds BH4 molecule as a cofactor which is shown here as spheres. The homo-tetrameric PAH has a two-fold symetry, which is drawn here as dashed black line (Flydal, M. I. et al., 2019)) (top)
- 19:21, 30 April 2021 (hist) (diff) Image:Obr.2.png (Fig. 2. Model of domain organization in one PAH monomer. Regulatory N-terminal domain is in blue, catalytic C-terminal domain is in yellow, tetramerization domain is in green, iron ion bound by the catalytic domain is in red (12).) (top)
- 19:18, 30 April 2021 (hist) (diff) Image:Fig.1.png (Crystal structure of human tetrameric PAH. Each monomere binds BH4 molecule as a cofactor which is shown here as spheres. The homo-tetrameric PAH has a two-fold symetry, which is drawn here as dashed black line (10).) (top)
(Newest | Oldest) View (Newer 50) (Older 50) (20 | 50 | 100 | 250 | 500)
